Levothroid and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Levothroid (levothyroxine sodium), especially for people who are female, 60+ old, also take Lipitor, and have Interstitial lung disease.

The phase IV clinical study analyzes which people have Ipf when taking Levothroid. It is created by eHealthMe based on reports of 8,088 people who have side effects when taking Levothroid from the FDA, and is updated regularly.

What is Levothroid?

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 8,973 Levothroid users. Check the latest studies of Levothroid.

What is Ipf?

Ipf is found to be associated with 2,029 drugs and 2,253 conditions by eHealthMe. Check the latest studies of Ipf.

On Jan, 10, 2026

8,088 people reported to have side effects when taking Levothroid.
Among them, 16 people (0.2%) have Ipf.

Among these 16 people:

What is the gender of people who have Ipf when taking Levothroid? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Ipf when taking Levothroid? *

What are other drugs people take besides Levothroid? *

What are other side effects people have besides Ipf? *

Hypotension (abnormally low blood pressure): 5 people, 31.25%
Diarrhea: 4 people, 25.00%
Cough: 4 people, 25.00%
High Blood Pressure: 4 people, 25.00%
Dyspnea (difficult or laboured breathing): 3 people, 18.75%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 3 people, 18.75%
Fatigue (feeling of tiredness): 3 people, 18.75%
Stress And Anxiety: 3 people, 18.75%
Bunion (a painful swelling on the first joint of the big toe): 2 people, 12.50%
Neuronal Neuropathy (damage of nerve with an electrically excitable cell that processes and transmits information through electrical and chemical signals): 2 people, 12.50%

What are the existing conditions these people have? *

Pain: 2 people, 12.50%
Osteoporosis (bones weak and more likely to break): 2 people, 12.50%
Osteopenia (a condition where bone mineral density is lower than normal): 2 people, 12.50%
Interstitial Lung Disease: 2 people, 12.50%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 6.25%
Stress And Anxiety: 1 person, 6.25%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 6.25%
Oral Herpes (viral infection of mouth): 1 person, 6.25%
Hypersensitivity: 1 person, 6.25%
High Blood Pressure: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Levothroid and have Ipf?

- Check whether Ipf is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levothroid:

Levothroid (8,973 reports)

Ipf treatments and more:

Ipf (79,192 reports)

Browse all side effects of Levothroid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (2,024 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,253 conditions)

Drugs similar to Levothroid and Ipf :

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium (the active ingredients of Levothroid) and Levothroid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.